Loading organizations...
Shoulder Innovations, Inc. develops and commercializes advanced medical devices for shoulder arthroplasty. The company focuses on implant products designed to address various shoulder surgical care needs, serving both hospital and ambulatory surgery center environments. Their approach involves creating innovative solutions aimed at improving outcomes for patients and streamlining procedures for surgeons.
The company was founded in 2009 by Dr. Steve Gunther, with initial involvement from venture capital firm EDF Ventures. Dr. Gunther's expertise in the orthopedic field likely provided the foundational insight for addressing specific challenges within shoulder surgery. His vision for enhanced implant technology drove the company's early development and market entry.
Shoulder Innovations' products cater to patients requiring shoulder replacement, as well as the surgeons performing these procedures and the administrative teams managing healthcare facilities. The long-term vision centers on transforming the entire shoulder surgical care market through continuous innovation in its product lines. The company aims to lead advancements that redefine treatment standards.
Shoulder Innovations, Inc. has raised $45.0M across 1 funding round.
Shoulder Innovations, Inc. has raised $45.0M in total across 1 funding round.
Shoulder Innovations, Inc. has raised $45.0M in total across 1 funding round.
Shoulder Innovations, Inc.'s investors include NFX.
Shoulder Innovations, Inc. (NYSE: SI) is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market through advanced implant systems for shoulder arthroplasty.[1][2][3] It builds products like the InSet® Glenoid and InSet® Reverse systems, which address clinical challenges such as the "rocking horse effect" in implants, delivering greater mechanical stability, predictable outcomes, procedural simplicity, and efficiency for surgeons, patients, and administrators in hospitals and ambulatory surgery centers (ASCs).[1][2][5] The company serves orthopedic surgeons treating patients with severe arthritis—especially younger, active individuals—and solves problems like implant loosening, rotator cuff sacrifice in reverse procedures, and operational inefficiencies, while showing strong growth momentum with increased full-year revenue guidance in Q3 2025.[3]
Shoulder Innovations traces its roots to 2009, when orthopedic surgeon Dr. Steve Gunther, practicing in Northern California, invented the core InSet® Glenoid technology to tackle a key issue: young, healthy patients suffering severe shoulder arthritis where traditional reverse shoulder arthroplasty required sacrificing the rotator cuff, limiting activity.[2] Frustrated by the "rocking horse effect"—where glenoid implants loosen due to instability—Gunther developed an inset design that embeds the implant deeper into the scapula bone for enhanced stability.[1][2]
The company was formally founded in 2009 as Shoulder Innovations, LLC (a Delaware entity) by Dr. Gunther and venture capital firm EDF Ventures.[1][2] In 2014, Genesis Innovation Group acquired a stake after reviewing the technology, bringing expertise in shoulder medical device development and commercialization, which propelled the company forward.[2] It converted to a C-corporation in February 2017 and went public on the NYSE under ticker SI.[1]
Shoulder Innovations stands out in the shoulder arthroplasty market through targeted innovations and a holistic ecosystem:
Shoulder Innovations rides the wave of advancing orthopedic medtech, particularly in shoulder arthroplasty, amid rising demand for joint replacements driven by an aging population, active lifestyles extending into later years, and a shift toward value-based care in ASCs.[1][3][5] Timing is ideal as minimally invasive, durable implants address unmet needs in younger patients with severe arthritis, where traditional options fall short—reducing revision surgeries and costs in a market plagued by high failure rates.[2] Favorable forces include regulatory tailwinds for innovative implants, surgeon adoption of evidence-based tech, and economic pressures favoring efficient systems; the company influences the ecosystem by fostering surgeon-to-surgeon collaboration and setting benchmarks for procedural simplicity, potentially accelerating broader adoption of inset designs.[1][2]
Shoulder Innovations is poised for accelerated growth, building on Q3 2025 revenue beats and raised guidance, with expansion of its InSet® portfolio and ecosystem into more ASCs and international markets.[3] Trends like AI-enhanced preoperative planning, personalized implants via 3D printing, and payer demands for cost-effective durability will shape its path, amplifying its edge in a consolidating orthopedics sector. Its influence may evolve from niche innovator to market leader, redefining shoulder care standards as clinical data accumulates—echoing its origin in solving real-world surgeon pain points for transformative patient impact.[1][2][3]
Shoulder Innovations, Inc. has raised $45.0M across 1 funding round. Most recently, it raised $45.0M Series D in February 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2023 | $45.0M Series D | NFX |